India Sees 1.28 Lakh New Cervical Cancer Cases in 2022
Cervical cancer remains a significant health issue for Indian women, with prevention and early detection being crucial.
Cervical cancer is the second most common cancer among Indian women, with 1.28 lakh new cases reported in 2022.
HPV vaccination and regular cervical screening are essential for prevention and early detection.
WHO's 90-70-90 strategy aims for comprehensive vaccination and screening to combat cervical cancer.
In 2022, India reported approximately 1.28 lakh new cases of cervical cancer, making it the second most prevalent cancer among women in the country, following breast cancer. This alarming statistic underscores the urgent need for effective prevention and early detection strategies. Experts emphasize that cervical cancer is largely preventable, primarily caused by persistent infections from high-risk types of human papillomavirus (HPV). The key to combating this disease lies in timely access to healthcare services, including vaccination and regular screenings.
The World Health Organization (WHO) has identified cervical cancer as a major public health concern and has set ambitious targets to eliminate it as a health issue. The WHO's 90-70-90 strategy aims for 90% of girls to be vaccinated against HPV by age 15, 70% of women to be screened with a high-performance test by ages 35 and 45, and 90% of women diagnosed with cervical disease to receive appropriate treatment. These measures are crucial in reducing the incidence of cervical cancer and improving women's health outcomes.
Despite the availability of preventive measures, many women still face challenges in recognizing the warning signs of gynecological cancers. Symptoms such as abnormal vaginal bleeding, persistent bloating, and changes in bowel habits can often be dismissed as routine health issues. However, experts urge women to seek medical evaluation for persistent or unusual symptoms, especially if they have a family history of ovarian or breast cancer. Early detection can significantly improve treatment outcomes and survival rates.
Cultural stigma surrounding discussions of women's health issues often leads to delayed diagnoses. It is essential for families to foster an environment where topics like HPV vaccination and gynecological health can be openly discussed. Empowering women to seek medical advice without embarrassment and encouraging family support can play a vital role in improving access to preventive healthcare services.
Looking ahead, the fight against gynecological cancers, particularly cervical cancer, requires a multifaceted approach that includes vaccination, awareness, and regular screenings. The WHO has designated November 17 as World Cervical Cancer Elimination Day, reflecting a global commitment to eradicating this disease. As healthcare systems continue to evolve, the focus must remain on prevention and early detection, as these are the most effective strategies in the battle against cancer.



